Skip to main content
Clinical Trials/NCT03602846
NCT03602846
Completed
Not Applicable

Diabetes in Pregnancy, Therapy and Pregnancy Outcomes

Tarumanagara University0 sites45 target enrollmentJanuary 2015

Overview

Phase
Not Applicable
Intervention
Medical Nutrition Therapy
Conditions
Diabetes Mellitus in Pregnancy
Sponsor
Tarumanagara University
Enrollment
45
Primary Endpoint
APGAR Score
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

To compare the clinical, glycemic profile and therapy as well as pregnancy complications and infant mortality among diabetic mothers in Indonesia.

Detailed Description

Pregnancy is a diabetogenic state with increasing burden on the mother's metabolism. Insulin resistance is often found during pregnancy leading to a compensatory increase in pancreatic β-cell response and eventually hyperinsulinemia. Undiagnosed and untreated diabetes in pregnancy have been shown to be linked with numerous comorbidities and complications to both mother and foetus. This study aims to compare the clinical, glycemic profile along with comorbidities, management and outcomes of diabetic mothers. Pregnant mothers with gestational and pregestational diabetes diagnosed under the ICD-10 coding of O24 were included in this study. The inclusion criteria was all patients with primary diagnosis of O24, have visited the clinic at least twice with a complete record of glycemic profile, management and fetal outcomes.

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
June 2016
Last Updated
7 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Tarumanagara University
Responsible Party
Principal Investigator
Principal Investigator

Anthony Paulo Sunjaya

Principle Investigator

Tarumanagara University

Eligibility Criteria

Inclusion Criteria

  • Clinical and laboratory diagnosis of Diabetes in Pregnancy (Gestational and Pregestational diabetes)
  • Mothers must have visited the clinic at least twice throughout their pregnancy, at least one at the first trimester and one at the third trimester

Exclusion Criteria

  • Pregnancy is still undergoing
  • Incomplete record of glycemic profile, management and fetal outcomes

Arms & Interventions

Good Outcome

Good outcome is defined as the safe delivery of the newborn.

Intervention: Medical Nutrition Therapy

Good Outcome

Good outcome is defined as the safe delivery of the newborn.

Intervention: Insulin

Good Outcome

Good outcome is defined as the safe delivery of the newborn.

Intervention: Oral Antidiabetics

Poor Outcome

Poor outcome is defined as the incidence of fetal demise during pregnancy.

Intervention: Medical Nutrition Therapy

Poor Outcome

Poor outcome is defined as the incidence of fetal demise during pregnancy.

Intervention: Insulin

Poor Outcome

Poor outcome is defined as the incidence of fetal demise during pregnancy.

Intervention: Oral Antidiabetics

Outcomes

Primary Outcomes

APGAR Score

Time Frame: At time of delivery

One and five minute APGAR Scores as recorded in medical records

Infant Mortality

Time Frame: Throughout the length of pregnancy, an average of 9 months

Infant Mortality either due to abortion, intrauterine fetal death or stillbirth as recorded in medical records

Infant Head Circumference

Time Frame: At time of delivery

Infant Head Circumference as recorded in medical records

Gestational Age at Birth

Time Frame: At time of delivery

Infant Gestational at Birth as recorded in medical records

Infant Body Weight

Time Frame: At time of delivery

Infant Body Weight as recorded in medical records

Infant Body Length

Time Frame: At time of delivery

Infant Body Length as recorded in medical records

Secondary Outcomes

  • Maternal Mortality(Throughout the length of pregnancy, an average of 9 months)
  • Comorbidities(Throughout the length of pregnancy, an average of 9 months)
  • Method of Delivery(At time of delivery)

Similar Trials